Metabolic characterization of triple negative breast cancer. - sprookjes - yvandenbroek - TriplyDB

Metabolic characterization of triple negative breast cancer.

Metabolic characterization of triple negative breast cancer.

http://www.wikidata.org/entity/Q34967995

about

Evaluation of Cancer Metabolomics Using ex vivo High Resolution Magic Angle Spinning (HRMAS) Magnetic Resonance Spectroscopy (MRS)Targeting metabolism in breast cancer: How far we can go?Metabolic reprogramming: the emerging concept and associated therapeutic strategies On metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancer Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer Molecular Effects of Doxorubicin on Choline Metabolism in Breast Cancer.Metabolic Portraits of Breast Cancer by HR MAS MR Spectroscopy of Intact Tissue Samples.Racial disparity in metabolic regulation of cancer.Metabolomics of Breast Cancer Using High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopy: Correlations with 18F-FDG Positron Emission Tomography-Computed Tomography, Dynamic Contrast-Enhanced and Diffusion-Weighted Imaging MRI Impact of Freezing Delay Time on Tissue Samples for Metabolomic Studies.EMT-induced metabolite signature identifies poor clinical outcome.Intratumoral Agreement of High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopic Profiles in the Metabolic Characterization of Breast Cancer.The Impact of Soy Isoflavones on MCF-7 and MDA-MB-231 Breast Cancer Cells Using a Global Metabolomic Approach.The Poly (ADP-Ribose) Polymerase Inhibitor Veliparib and Radiation Cause Significant Cell Line Dependent Metabolic Changes in Breast Cancer Cells.A plasma metabolomic signature discloses human breast cancer.In vivo Reprogramming of Cancer Metabolism by MYC.Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities.Differences in elongation of very long chain fatty acids and fatty acid metabolism between triple-negative and hormone receptor-positive breast cancer.Magnetic resonance metabolic profiling of estrogen receptor-positive breast cancer: correlation with currently used molecular markers.Endogenous glutamine decrease is associated with pancreatic cancer progression.MYC regulation of glutamine-proline regulatory axis is key in luminal B breast cancer.Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptations.Applications of high-resolution magic angle spinning MRS in biomedical studies II-Human diseases.Metabolic Footprints and Molecular Subtypes in Breast Cancer.Metabolic profiles of triple-negative and luminal A breast cancer subtypes in African-American identify key metabolic differences.Metabolic consequences of HIF silencing in a triple negative human breast cancer xenograft.Metabolic profiling of synovial tissue shows altered glucose and choline metabolism in rheumatoid arthritis samples.Amino Acid Transporters and Glutamine Metabolism in Breast Cancer.Metabolomics research on potential role for 9-cis-retinoic acid in breast cancer progression.

P2860

Q26751944-A8802DCC-15BF-416A-8CB0-F91CD862C0B0 Q26767022-448C9A24-9C23-4966-9F02-6B5016244878 Q26786595-3B43711D-6696-40B4-8874-4092AF7CED8A Q28072798-8039C1D5-1297-45CD-8CB7-B83AAAE43E88 Q28074613-4606FB93-95CE-4890-8016-92E03C19C55A Q33842777-9AAE2E5C-254C-4329-9E38-23CBC5B2132F Q33844930-3FCA9D08-0473-4BF7-95FD-E007AB2384C5 Q33906704-37536C2C-4DCF-4855-A614-5BBDAE9C91A6 Q36086056-7A367584-2234-4FD1-9824-3FBFD6732F3D Q36514020-6DD4B094-8720-48A8-B99F-BCB5D43D5F28 Q36618962-838C6C40-2F5F-4E12-8809-B221D0F843DB Q36822535-996BDB05-3979-4687-A3DD-4CCF7538AC25 Q37286373-9AAA89E4-0B6E-4CE0-AE12-356608F220F6 Q37394040-C8553C8B-F1D9-4DF1-95C2-8C28DA6E010E Q37746050-E634FFB2-2064-46E8-BB0A-1750B1A2D0B8 Q37746816-D8552586-A00E-4AF6-8884-F348DCC90085 Q38693843-E9480EDB-704C-49BE-AAE1-B523F3FED62C Q41557835-80EEB4A2-ABE0-4B6E-AF13-69F5884386D3 Q42362672-DE25892D-7E84-486A-BDD8-988FCE858930 Q47095381-D00D85F7-3835-4CF8-9408-ADAE2AF383E8 Q47370695-B12A11FD-5C3C-4085-BDE7-5B62B498BB21 Q48056590-2584FC06-69B7-4BB2-82FA-4EF92BF5FC16 Q48338205-E3DDA8CE-92D7-41FE-BECB-3664A0026F95 Q49871101-7FEAD5C0-67C5-4DA6-8928-1F352EC576BE Q52353599-AAE65B17-BCEA-4980-A2D9-B2AA66D1F27A Q52597601-654FA833-312E-4463-807D-634DF8D0A00B Q53118313-4E9DB3EC-0B3C-43FD-A938-7B4C42CC7F14 Q54957053-6CE1B31E-9A41-4BD2-8FAA-D30D03689746 Q55518177-A3AE34BA-937A-46D8-A6C5-CDB1A9C5256A

P2860

Metabolic characterization of triple negative breast cancer.

http://www.wikidata.org/entity/Q34967995

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Metabolic characterization of triple negative breast cancer.

@ast

Metabolic characterization of triple negative breast cancer.

@en

Metabolic characterization of triple negative breast cancer.

@nl

type

label

Metabolic characterization of triple negative breast cancer.

@ast

Metabolic characterization of triple negative breast cancer.

@en

Metabolic characterization of triple negative breast cancer.

@nl

prefLabel

Metabolic characterization of triple negative breast cancer.

@ast

Metabolic characterization of triple negative breast cancer.

@en

Metabolic characterization of triple negative breast cancer.

@nl

P1433

Q34967995-4FDB29CE-81C2-4C90-A4AC-699FB928E42A

P1476

Q34967995-5695DAD2-E696-44B8-85D9-6589240AA57B

P2093

Q34967995-07424609-AD6C-438C-8885-8F22843D6DA2

Q34967995-08511EAB-B6F9-418F-BDA3-A38D2A10C4F5

Q34967995-0C359DBA-1FD8-4311-B137-D9146F1EE281

Q34967995-273876FF-A5C9-4CE4-A6A7-73502B3CD0B5

Q34967995-E6B143E3-0597-41E8-8B81-DDB951AF21D5

P2860

Q34967995-03237408-62AB-4C16-BE6E-1E21D0664290

Q34967995-040CF8A4-48F2-4692-AB64-187CE33564F0

Q34967995-060ACD6F-F30A-44D1-B22A-62A9163F39A4

Q34967995-0764692F-DEA6-49E8-9C16-212913D5CEDC

Q34967995-0C71FE62-18FC-4871-B770-5F15839C9669

Q34967995-0F58D5DE-E3DF-4CD3-B0FD-61F07288C96B

Q34967995-11BF57DD-10D5-4871-8CF3-9F7235A58328

Q34967995-1363A466-C3EF-41AE-A08A-121E596FC445

Q34967995-1BB85592-456D-4510-960A-D43F1E69407E

Q34967995-21D37BCA-96E4-4E4C-98E4-AA81D9BCA080

P2888

Q34967995-1EDADD2E-6924-4067-BE40-D47ECF5C9296

P304

Q34967995-8D885C3A-0FAD-4CF2-B4F6-FC325189D5A2

P31

Q34967995-BA2EC689-64DA-447C-8585-8220BC96879B

P356

Q34967995-17C5F966-7438-4D3D-B32F-D80556D6A171

P407

Q34967995-7271DA53-0BB5-4FEE-8A01-E48FC67E6869

P478

Q34967995-BAFD012A-E754-4AD5-AD18-E61DE4F3CF8B

P50

Q34967995-50F42D54-4CA8-43A1-9F8D-C0E98F3C365B

Q34967995-8F0866D9-5340-478E-8627-D4C9B60A4874

P577

Q34967995-D138B738-5739-4729-BFA4-305D40A8DDA1

P5875

Q34967995-B085EE54-DBB0-4BC3-A884-CCAD5F2FD1D2

P6179

Q34967995-3F500CBD-848E-4482-A0AA-B17056ACF7E4

P698

Q34967995-264BB6EB-0DAB-4151-A5A5-85E1CB317D18

P932

Q34967995-0F602B0D-7F48-463C-8033-01A180CEE7AD

P356

1471-2407-14-941

P1433

P1476

Metabolic characterization of triple negative breast cancer.

@en

P2093

Anna Bofin

http://www.w3.org/2001/XMLSchema#string

Guro F Giskeødegård

http://www.w3.org/2001/XMLSchema#string

Hans Fjøsne

http://www.w3.org/2001/XMLSchema#string

Maria D Cao

http://www.w3.org/2001/XMLSchema#string

Santosh Lamichhane

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting aspartate aminotransferase in breast cancer

Hallmarks of Cancer: The Next Generation

Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies.

The omics of triple-negative breast cancers

Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells

Bidirectional transport of amino acids regulates mTOR and autophagy

Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models

Personalizing HER2-targeted therapy in metastatic breast cancer beyond HER2 status: what we have learned from clinical specimens

Merging transcriptomics and metabolomics--advances in breast cancer profiling.

Effects of lovastatin on breast cancer cells: a proteo-metabonomic study.

P2888

1471-2407-14-941

P304

941

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-14-941

http://www.w3.org/2001/XMLSchema#string

P407

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Steinar Lundgren

P577

2014-12-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269720861

http://www.w3.org/2001/XMLSchema#string

P6179

1050253005

http://www.w3.org/2001/XMLSchema#string

P698

25495193

http://www.w3.org/2001/XMLSchema#string

P932

4295321

http://www.w3.org/2001/XMLSchema#string